Left Main Protection During very High Risk Transcatheter Aortic Valve-in-Valve Procedure. A Collaborative Registry

Left Main Protection During very High Risk Transcatheter Aortic Valve-in-Valve Procedure. A Collaborative Registry

Background: Surgically implanted aortic bio-prostheses are prone to degeneration and eventually failure within 10 to 20 years. Transcatheter aortic valve replacement “valve-in-valve” (TAVR-VIV) is an effective treatment for patients deemed at prohibitive risk for surgical redo. However, Mitroflow, F...

Full description

Bibliographic Details
Main Authors: Luca Testa, Tarun Chakravarty, Azeem Latib, Fausto Castriota, Montone RA, Alberto Cremonesi, Antonio Colombo, Raj Makkar, Francesco Bedogni
Format: Article
Language:English
Published: Barcaray International 2016-01-01
Series:International Cardiovascular Forum Journal
Subjects:
degenerated aortic bioprosthesis
valve in valve
left main occlusion
Online Access:http://icfjournal.org/index.php/icfj/article/view/169/pdf-2

Internet

http://icfjournal.org/index.php/icfj/article/view/169/pdf-2

Similar Items